Cognito Therapeutics vs NRG Therapeutics

Cognito Therapeutics vs NRG Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cognito Therapeutics is on 50/100 and NRG Therapeutics on 42/100.

Cognito Therapeutics logo
Cognito TherapeuticsDeveloping a novel therapeutic approach for Alzheimer's disease.
Try Cognito Therapeutics
NRG Therapeutics logo
NRG TherapeuticsA biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.
Try NRG Therapeutics

Where each one leads

Cognito Therapeutics

  • our overall score: 50/100 against 42/100
  • agent readiness: 33/100 against 25/100
  • domain rating: 47/100 against 27/100
  • funding raised: $213M against $58.6M

NRG Therapeutics

Leads on none of the measures we hold for both companies.

At a glance

MeasureCognito TherapeuticsNRG Therapeutics
What it isDeveloping a novel therapeutic approach for Alzheimer's disease.A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.
CategoryBiotechnology, Medical Devices, Neuroscience, HealthcareBiotech, MedTech, Drug Discovery, Neurodegenerative Diseases
Sells toBusiness modelB2B2CB2B
OfferingHardwareSoftware
Founded2011Not published
HeadquartersBoston, USAStevenage, United Kingdom
StatusActiveActive

Size, funding and growth

MeasureCognito TherapeuticsNRG Therapeutics
EmployeesNot published23
Total funding$213M$58.6M
Latest roundSeries CSeries B
Valuation$487MNot published
LinkedIn followersNot published4,252

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCognito TherapeuticsNRG Therapeutics
StartupHub scoreOur 0-100 rating50/10042/100
Traction40/10053/100
Team60/100Not published
Search visibility10/10024/100
Quality65/10050/100
Agent readinessHow well an AI agent can read and act on the siteF (33/100)F (25/100)
Domain ratingLink authority, 0-10047/10027/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCognito TherapeuticsNRG Therapeutics
HostingNot detectedSelf Managed
CDNCloudflareNot detected
CMSWebflowNot detected
FrameworksNot detectedBootstrap
AnalyticsGoogle Tag ManagerGoogle Analytics 4
Open sourceYesNo

Cognito Therapeutics vs NRG Therapeutics: common questions

Which is better, Cognito Therapeutics or NRG Therapeutics?

On our 0-100 score Cognito Therapeutics rates higher (50/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Cognito Therapeutics and NRG Therapeutics compare on the numbers?

Cognito Therapeutics leads on our overall score (50/100 against 42/100), agent readiness (33/100 against 25/100), domain rating (47/100 against 27/100), funding raised ($213M against $58.6M).

Read the full Cognito Therapeutics review and pricing or the NRG Therapeutics review and pricing. You can also browse other Cognito Therapeutics alternatives we track.